Current Assets (USD, thousands)

Cash and Cash Equivalents (USD, thousands)

Accounts Receivable (USD, thousands)

Inventory (USD, thousands)

Non-Current Assets (USD, thousands)

Property, Plant, and Equipment (PP&E) (USD, thousands)

Goodwill (USD, thousands)

Intangible Assets (USD, thousands)

Current Liabilities (USD, thousands)

Accounts Payable (USD, thousands)

Short-term Debt (USD, thousands)

Accrued Expenses (USD, thousands)

Non-Current Liabilities (USD, thousands)

Long-term Debt (USD, thousands)

Lease Liabilities (USD, thousands)

Deferred Tax Liabilities (USD, thousands)

Shareholders' Equity (USD, thousands)

Retained Earnings (USD, thousands)

Common Stock (USD, thousands)

Additional Paid-in Capital (USD, thousands)

91dcbd69cd2893bfc6bcce5af56c5d4b705df95dbadef875db9e70628dbb1993

Adjustments for Non-Cash Items (USD, thousands)

Stock-Based Compensation (USD, thousands)

Changes in Working Capital (USD, thousands)

Capital Expenditures (CapEx) (USD, thousands)

Proceeds from / Repayments of Debt (USD, thousands)

Share Repurchases (USD, thousands)

Dividend Payments (USD, thousands)

Net Change in Cash (USD, thousands)

760cc64bbc61a41195882ce3b5979dac109f7b4abf8c907df55dd99da941cb4b

Total Revenue (USD, thousands)

Cost of Goods Sold (COGS) (USD, thousands)

Selling, General, and Administrative Expenses (SG&A) (USD, thousands)

Research and Development (R&D) (USD, thousands)

Depreciation and Amortization (D&A) (USD, thousands)

Interest Expense (USD, thousands)

Operating Income (EBIT) (USD, thousands)

Net Income (USD, thousands)

Earnings Per Share (EPS) - Basic (USD)

Earnings Per Share (EPS) - Diluted (USD)

f589b151ce2b6e1bc4eeee833a9828f6cf4e4bf78ed434a2ce40ba899c2ed9f4

Baker Hughes Worldwide Average Rig Count (rigs)

Baker Hughes U.S. Average Rig Count (rigs)

Baker Hughes U.S. Land-based Average Rig Count (rigs)

Baker Hughes Worldwide Year-End Rig Count (rigs)

Baker Hughes U.S. Year-End Rig Count (rigs)

Baker Hughes U.S. Land-based Year-End Rig Count (rigs)

Average Crude Oil Price per Barrel WTI (USD per barrel)

Average Crude Oil Price per Barrel Brent (USD per barrel)

Average Natural Gas Price per MMBtu (USD per MMBtu)

Year-end Crude Oil Price per Barrel WTI (USD per barrel)

Year-end Crude Oil Price per Barrel Brent (USD per barrel)

Year-end Natural Gas Price per MMBtu (USD per MMBtu)

0e53336b20426f1f72b84e2ebf2a913c72695176ee43a827740abf28e29ec53d

United States

Europe/Africa/Middle East

Asia Pacific

Canada

Former Soviet Union

Latin/South America

- Other Countries (Combined)

Total Revenue

781a4bd8b92564ee3c8a090d2bc4239cf8041fd78eeea74cb97f97ecb6343943

Stock-based compensation (USD, thousands)

Depreciation and amortization (USD, thousands)

Deferred income taxes (USD, thousands)

Accounts receivable (Change, USD, thousands)

Inventories (Change, USD, thousands)

Accounts payable (Change, USD, thousands)

Other adjustments to net income (USD, thousands)

Assets write-down (USD, thousands)

Inventory write-off and obsolescence (USD, thousands)

Changes in value of life insurance policies (USD, thousands)

Gain on insurance recovery on property, plant and equipment (USD, thousands)

Realization of pension obligation (USD, thousands)

Net provision for credit losses (USD, thousands)

Other non-cash items (USD, thousands)

Prepaid expenses and other current assets (Change, USD, thousands)

Other assets (Change, USD, thousands)

Accrued expenses (Change, USD, thousands)

Unearned revenues (Change, USD, thousands)

Other liabilities (Change, USD, thousands)

Net cash provided by operating activities (USD, thousands)

Capital expenditures (Investing) (USD, thousands)

Capital expenditures - operations (Investing) (USD, thousands)

Capital expenditures - rebuilding of Aberdeen facility (Investing) (USD, thousands)

Patents and other intangibles (Investing) (USD, thousands)

Proceeds from sale of assets (Investing) (USD, thousands)

Proceeds from sale of business, net of cash sold (Investing) (USD, thousands)

Proceeds from insurance recovery (Investing) (USD, thousands)

Net proceeds from insurance recovery (Investing) (USD, thousands)

Net proceeds on life insurance policies (Investing) (USD, thousands)

Other investing activities (USD, thousands)

Net cash provided by (used in) investing activities (USD, thousands)

Repayment of long-term debt (Financing) (USD, thousands)

Proceeds from long-term debt (Financing) (USD, thousands)

Debt issuance costs (Financing) (USD, thousands)

Equity related transaction costs (Financing) (USD, thousands)

Equity related transaction costs and other financing activities (Financing) (USD, thousands)

Dividends paid (Financing) (USD, thousands)

Repurchase of common stock (Financing) (USD, thousands)

Other financing activities (Financing) (USD, thousands)

Net cash used in financing activities (USD, thousands)

Net change in cash and cash equivalents (USD, thousands)

Cash payments for interest (Supplemental) (USD, thousands)

Cash payments for income taxes (Supplemental) (USD, thousands)

Capital expenditures incurred but not paid for as of the end of the period (Supplemental) (USD, thousands)

Equity related transaction costs incurred but not paid for as of the end of the period (Supplemental) (USD, thousands)

Cash and cash equivalents, beginning of period (USD, thousands)

Cash and cash equivalents, end of period (USD, thousands)

14eaf514a21af55ec770f4132281f9a4df2397bd50ea3d78933149e00772c666

Services Revenue (USD, thousands)

Product sales Revenue (USD, thousands)

Cost of services and product sales (USD, thousands)

General and administrative expense (USD, thousands)

Other (income) expense, net (USD, thousands)

Total operating expenses (USD, thousands)

OPERATING INCOME (USD, thousands)

Interest expense (USD, thousands)

Income before income taxes (USD, thousands)

Income tax expense (benefit) (USD, thousands)

Net income (USD, thousands)

Net income attributable to non-controlling interest (USD, thousands)

Net income (loss) attributable to Core Laboratories Inc. (USD, thousands)

Basic earnings per share (USD)

Basic earnings per share attributable to Core Laboratories Inc. (USD)

Diluted earnings per share (USD)

Diluted earnings (loss) per share attributable to Core Laboratories Inc. (USD)

Weighted average common shares outstanding - Basic (shares)

Weighted average common shares outstanding - Diluted (shares)

Effective tax rate (%)

1646a4d0a0696b17ab02526f354f466264305212ee293c70f36eb717c952e1ca

Cash and cash equivalents (In thousands)

Accounts receivable, net (In thousands)

Inventories (In thousands)

Prepaid expenses (In thousands)

Income taxes receivable (In thousands)

Other current assets (In thousands)

TOTAL CURRENT ASSETS (In thousands)

PROPERTY, PLANT AND EQUIPMENT, net (In thousands)

RIGHT OF USE ASSETS (In thousands)

INTANGIBLES, net (In thousands)

GOODWILL (In thousands)

DEFERRED TAX ASSETS, net (In thousands)

OTHER ASSETS (In thousands)

Intangibles, goodwill and other long-term assets, net (In thousands)

TOTAL ASSETS (In thousands)

Accounts payable (In thousands)

Accrued payroll and related costs (In thousands)

Taxes other than payroll and income (In thousands)

Unearned revenues (In thousands)

Operating lease liabilities (Current) (In thousands)

Income taxes payable (In thousands)

Other current liabilities (In thousands)

TOTAL CURRENT LIABILITIES (In thousands)

LONG-TERM DEBT, net (In thousands)

LONG-TERM OPERATING LEASE LIABILITIES (In thousands)

DEFERRED COMPENSATION (In thousands)

DEFERRED TAX LIABILITIES, net (In thousands)

OTHER LONG-TERM LIABILITIES (In thousands)

Preference stock (In thousands)

Common stock (In thousands)

Additional paid-in capital (In thousands)

Retained earnings (In thousands)

Accumulated other comprehensive income (loss) (In thousands)

Treasury stock (at cost) (In thousands)

Total Core Laboratories Inc. shareholders' equity (In thousands)

Non-controlling interest (In thousands)

TOTAL EQUITY (In thousands)

TOTAL LIABILITIES AND EQUITY (In thousands)

915822984026d3445d08070db85b1b2e892fb4041cce688294106e35453b5284

Reservoir Description

- Services

- Product Sales

Production Enhancement

Services

Product Sales

8cd1c0bac2ba7f47d1992343caa089996e57a52cf97660eebe08af5cac5bb666

Core Laboratories Inc (CLB)

Financials